Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - StockTitan
GRCE Stock | 3.58 0.32 8.21% |
About 62% of Grace Therapeutics,'s investor base is looking to short. The analysis of overall sentiment of trading Grace Therapeutics, stock suggests that many investors are alarmed at this time. The current market sentiment, together with Grace Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Grace Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Grace |
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. StockTitan
Read at news.google.com
Grace Therapeutics, Fundamental Analysis
We analyze Grace Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grace Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grace Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Grace Therapeutics, is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Grace Therapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Grace Therapeutics, stock to make a market-neutral strategy. Peer analysis of Grace Therapeutics, could also be used in its relative valuation, which is a method of valuing Grace Therapeutics, by comparing valuation metrics with similar companies.
Peers
Grace Therapeutics, Related Equities
VRPX | Virpax Pharmaceuticals | 33.33 | ||||
VRNA | Verona Pharma | 5.50 | ||||
VRTX | Vertex Pharmaceuticals | 0.08 | ||||
VNDA | Vanda Pharmaceuticals | 0.22 | ||||
VSTM | Verastem | 0.44 | ||||
VRDN | Viridian Therapeutics | 0.78 | ||||
VKTX | Viking Therapeutics | 1.75 | ||||
VTGN | VistaGen Therapeutics | 2.02 | ||||
VRCA | Verrica Pharmaceuticals | 5.00 |
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |